Videos

An Interview with Dr. Abolfazl Hosseni at the 11th National Endourology Congress, Discussing the Developing Treatment in Bladder Cancer

An Interview with Dr. Abhay Rane at the 11th National Endourology Congress, Discussing the Key Points of the Upcoming World Congess of Endourology

An Interview with Dr. John W. Davis at the 11th National Endourology Congress, Discussing the Key Points from the Congress

An Interview with Dr. Kevin C. Zorn at the 11th National Endourology Congress, Discussing Developments within the Field

Findings from a phase I/II study suggest that nivolumab is safe and effective in advanced liver cancer. Based on the results of the phase I part of the…

A phase II study identified the first genomic marker – mismatch repair (MMR) deficiency – to predict response to the anti-PD-1 antibody pembrolizumab…

Findings from a randomised phase III study indicate that PD-1 immunotherapy is an effective treatment option for patients with non-squamous, non-small…

Peter Paul Yu, MD, FACP, FASCO introduces ASCO 2015 and the conference themes – how to utilise data, to transform it into learning to impact patient care.